Operating Lease, Right-of-Use Asset of Serina Therapeutics, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Serina Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Serina Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $312,000, a 39% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Serina Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $312,000 -$197,000 -39% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $362,000 -$200,000 -36% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $412,000 -$215,000 -34% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $461,000 -$205,000 -31% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $509,000 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $562,000 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $627,000 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $666,000 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2020 $726,000 $0 0% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $726,000 +$99,000 +16% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $320,000 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $726,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $726,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $627,000 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.